Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: A meta-analysis

by Chee Khoon Lee, Chris Brown, Richard J. Gralla, Vera Hirsh, Sumitra Thongprasert, Chun Ming Tsai, Eng Huat Tan, James Chung Man Ho, Da Tong Chu, Adel Zaatar, Jemela Anne Osorio Sanchez, Vu Van Vu, Joseph Siu Kie Au, Akira Inoue, Siow Ming Lee, Val Gebski, James Chih Hsin Yang
Published 2018

Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: A meta-analysis

by Chee Khoon Lee, Chris Brown, Richard J. Gralla, Vera Hirsh, Sumitra Thongprasert, Chun Ming Tsai, Eng Huat Tan, James Chung Man Ho, Da Tong Chu, Adel Zaatar, Jemela Anne Osorio Sanchez, Vu Van Vu, Joseph Siu Kie Au, Akira Inoue, Siow Ming Lee, Val Gebski, James Chih Hsin Yang
Published 2018

Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study

by Chai, Chee Shee, Ho, Gwo Fuang, Adlinda, Alip, Mohd Ibrahim, Abd Wahid, Matin Mellor, Abdullah, Foo, Yoke Ching, How, Soon Hin, Adel, Zaatar, Lam, Kai Seng, Leong, Kin-Wah, Low, JohnbSeng Hooi, Mastura, Md Yusof, Lee, Erica Chai Yong, Toh, Yok Yong, Liam, Chong Kin
Published 2019